These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 4141694)

  • 1. Two myeloma globulins IgG1-kappa and IgG1-lambda, from a single patient (Im). II. Their common cellular origin as revealed by immunofluorescence studies.
    Bouvet JP; Buffe D; Oriol R; Liacopoulos P
    Immunology; 1974 Dec; 27(6):1095-101. PubMed ID: 4141694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two myeloma globulins, IgG1-kappa and IgG1-lambda, from a single patient (Im). I. Purification and immunochemical characterization.
    Oriol R; Huerta J; Bouvet JP; Liacopoulos P
    Immunology; 1974 Dec; 27(6):1081-93. PubMed ID: 4141693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double Bence Jones proteinuria.
    Kanoh T; Yago K
    Arch Pathol Lab Med; 1990 Sep; 114(9):991-4. PubMed ID: 2117911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunofluorescence optical studies for the differentiation of monoclonal and polyclonal increases in immunoglobulin producing bone marrow cells].
    Morell A; Mosimann W; Skvaril F; Barandun S
    Schweiz Med Wochenschr; 1974 Sep; 104(39):1395-6. PubMed ID: 4214489
    [No Abstract]   [Full Text] [Related]  

  • 5. Monoclonal IgG3-kappa and IgG1-lambda proteins with different idiotypic determinants present in a single patient.
    Sarasombath S; Mestecky J; Skvaril F
    Clin Exp Immunol; 1977 Jul; 29(1):67-74. PubMed ID: 70295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunochemical analysis of IgD-lambda paraprotein in myeloma.
    Tichý M; Hrncír Z; Pola V; Mazák J
    Neoplasma; 1974; 21(4):487-91. PubMed ID: 4215041
    [No Abstract]   [Full Text] [Related]  

  • 7. Intracytoplasmic and surface-bound immunoglobulins in "nonsecretory" and Bence-Jones myeloma.
    Preud'Homme JL; Hurez D; Danon F; Brouet JC; Seligmann M
    Clin Exp Immunol; 1976 Sep; 25(3):428-36. PubMed ID: 822974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human immunoglobulin light chain subgroups: serological typing.
    Rivat L; Rivat C; Ropartz C
    Ann Immunol (Paris); 1974; 125 C(5):697-703. PubMed ID: 4142370
    [No Abstract]   [Full Text] [Related]  

  • 9. [Monoclonal plasmocytic myeloma with 2 paraproteins, IgG kappa and IgG lambdal].
    Villiamey J; Bouvet JP; Di Menza C; Boccara M
    Nouv Presse Med; 1974 Dec; 3(45):2707-11. PubMed ID: 4142506
    [No Abstract]   [Full Text] [Related]  

  • 10. Characterization of an antiserum against human myeloma cells.
    Staneck LO; Krueger RG; Kyle RA
    J Natl Cancer Inst; 1974 Oct; 53(4):927-32. PubMed ID: 4214937
    [No Abstract]   [Full Text] [Related]  

  • 11. Individual antigenic specificity in immunoglobulins: relationship to biosynthesis.
    Nisonoff A; Fudenberg HH; Wilson SK; Hopper JE; Wang AC
    Fed Proc; 1972; 31(1):206-9. PubMed ID: 4109799
    [No Abstract]   [Full Text] [Related]  

  • 12. Characterization of antiserum against myeloma cells.
    Cawley LP; Goodwin WL; Minard BJ
    Cancer Res; 1973 Jan; 33(1):17-22. PubMed ID: 4629871
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of the immunological specificity of fluorescein-labelled anti-human IgM conjugates.
    Chantler S; Haire M
    Immunology; 1972 Jul; 23(1):7-12. PubMed ID: 4114650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of free lambda-chain of immunoglobulin produced by an established cell line of human myeloma cell origin. II. Identity of lambda-chains in cells and in medium.
    Matsuoka Y; Yagi Y; Moore GE; Pressman D
    J Immunol; 1969 Nov; 103(5):962-9. PubMed ID: 4187117
    [No Abstract]   [Full Text] [Related]  

  • 15. Release of a low molecular weight Fc-like fragment on reduction of water-insoluble IgG myeloma proteins.
    Morris GG; Osterland CK; Chaplin H
    Vox Sang; 1974; 27(4):273-86. PubMed ID: 4278247
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bence-Jones myeloma. Clinical aspects, analysis and evolution].
    Sanchez de cos Escuin J; Moreno Norueira J; Carneado de la Fuente J
    Rev Clin Esp; 1978 Sep; 150(6):345-9. PubMed ID: 103147
    [No Abstract]   [Full Text] [Related]  

  • 17. Preparation of fluorescent antibody reagents monospecific to heavy chains of human immunoglobulin.
    Takahashi M; Yagi Y; Pressman D
    J Immunol; 1968 Jun; 100(6):1169-75. PubMed ID: 4177024
    [No Abstract]   [Full Text] [Related]  

  • 18. [A case of multiple myeloma with alternating paraprotein; non-secretory myeloma (IgG-kappa) converted to nonproducing myeloma, and finally to secretory myeloma (BJ-lambda) (author's transl)].
    Fujii H; Kanoh T
    Nihon Naika Gakkai Zasshi; 1981 Nov; 70(11):1553-61. PubMed ID: 6801164
    [No Abstract]   [Full Text] [Related]  

  • 19. Determination of the light chain type of paraproteins, identification of heavy chain disease.
    Backhausz R; Lajos J
    Ann Immunol Hung; 1972; 16(0):43-50. PubMed ID: 4213025
    [No Abstract]   [Full Text] [Related]  

  • 20. Three monoclonal IgG components, an IgG4(lambda), an IgG2(kappa) and an IgG1/IgG3 (kappa) Gm(f,b) hybrid, in a single myeloma patient.
    Milosevic-Jovcic N; Dovezenski N; Jovanovic L; Rolovic Z; Gotic M; Radosevic N; Suvajdzic N; Tosic L
    Eur J Haematol; 1995 May; 54(5):288-95. PubMed ID: 7781753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.